Consistently, the CSF levels of all tryptic peptides of SNAP-25 were significantly higher in patients with Alzheimer’s disease compared with non-demented controls in the replication set (Figure 3D-F). This evidence concerns the gene SNAP25 and early-onset autosomal dominant Alzheimer disease.